feed,title,long_url,short_url
Yahoo,Patients Regain Weight After They Quit Using Ozempic Rival Zepbound. Here's Why That Makes Eli Lilly Stock an Even Better Buy.,https://finance.yahoo.com/news/patients-regain-weight-quit-using-105500420.html,https://da.gd/1vMle
